Literature DB >> 1940065

Post-partum hypercalcemia in hereditary hyperphosphatasia (juvenile Paget's disease).

N Chosich1, F Long, R Wong, D J Topliss, J R Stockigt.   

Abstract

Hereditary hyperphosphatasia is a rare bone disorder characterized by increased bone turnover, elevated alkaline phosphatase (ALP) and bone deformity. We describe a patient with a mild form of hereditary hyperphosphatasia who was initially hypercalcemic in childhood with remission after puberty. Symptomatic hypercalcemia recurred during lactation after each of two pregnancies, associated with increased bone turnover (rise in ALP, osteocalcin, and urine hydroxyproline excretion) which appeared to be independent of changes in major calcium-regulating hormones. The mechanism for the development of post-partum hypercalcemia remains unclear but may relate to the relative estrogen deficiency of lactation. We postulate that acute estrogen withdrawal may result in hypercalcemia in the presence of markedly increased bone turnover.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1940065     DOI: 10.1007/BF03346877

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  32 in total

1.  Serum concentrations of alkaline phosphatase isoenzymes and osteocalcin in normal pregnancy.

Authors:  A Rodin; A Duncan; H W Quartero; G Pistofidis; G Mashiter; K Whitaker; D Crook; J C Stevenson; M G Chapman; I Fogelman
Journal:  J Clin Endocrinol Metab       Date:  1989-06       Impact factor: 5.958

2.  Routine assay of total urinary hydroxyproline based on resin-catalysed hydrolysis.

Authors:  B C Goverde; F J Veenkamp
Journal:  Clin Chim Acta       Date:  1972-10       Impact factor: 3.786

3.  Hereditary hyperphosphatasia. Studies of three siblings.

Authors:  R C Thompson; G E Gaull; S J Horwitz; R K Schenk
Journal:  Am J Med       Date:  1969-08       Impact factor: 4.965

4.  Calcitonin treatment in hereditary bone dysplasia with hyperphosphatasemia: a radiographic and histologic study of bone.

Authors:  J P Whalen; M Horwith; L Krook; I MacIntyre; E Mena; F Viteri; B Torun; E A Nunez
Journal:  AJR Am J Roentgenol       Date:  1977-07       Impact factor: 3.959

5.  Familial hyperphosphatasemia: diagnosis in early infancy and response to human thyrocalcitonin therapy.

Authors:  V Dunn; V R Condon; M L Rallison
Journal:  AJR Am J Roentgenol       Date:  1979-04       Impact factor: 3.959

6.  A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone.

Authors:  D Thiébaud; P Jaeger; C Gobelet; A F Jacquet; P Burckhardt
Journal:  Am J Med       Date:  1988-08       Impact factor: 4.965

7.  Serum free 1,25-dihydroxyvitamin D and the free 1,25-dihydroxyvitamin D index during a longitudinal study of human pregnancy and lactation.

Authors:  S G Wilson; R W Retallack; J C Kent; G K Worth; D H Gutteridge
Journal:  Clin Endocrinol (Oxf)       Date:  1990-05       Impact factor: 3.478

8.  Expression of a calcium-mobilizing parathyroid hormone-like peptide in lactating mammary tissue.

Authors:  M A Thiede; G A Rodan
Journal:  Science       Date:  1988-10-14       Impact factor: 47.728

9.  Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease.

Authors:  D D Bikle; E Gee; B Halloran; J G Haddad
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  Changing osteocalcin concentrations during pregnancy and lactation: implications for maternal mineral metabolism.

Authors:  D E Cole; C M Gundberg; L J Stirk; S A Atkinson; D A Hanley; L M Ayer; L S Baldwin
Journal:  J Clin Endocrinol Metab       Date:  1987-08       Impact factor: 5.958

View more
  2 in total

1.  Juvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANK.

Authors:  Michael P Whyte; Cristina Tau; William H McAlister; Xiafang Zhang; Deborah V Novack; Virginia Preliasco; Eduardo Santini-Araujo; Steven Mumm
Journal:  Bone       Date:  2014-07-23       Impact factor: 4.398

2.  Early-onset Paget's disease of bone in a Mexican family caused by a novel tandem duplication (77dup27) in TNFRSF11A that encodes RANK.

Authors:  Sean J Iwamoto; Micol S Rothman; Shenghui Duan; Jonathan C Baker; Steven Mumm; Michael P Whyte
Journal:  Bone       Date:  2020-01-08       Impact factor: 4.398

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.